A Phase 1/2a, First-in-human, Study of BMS-986517 in Participants With Advanced Solid Tumors

NCT07160725 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
315
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bristol-Myers Squibb